Indications of initiation renal replacement therapy among patients with chronic renal disease
Abstract
Introduction: Chronic renal failure (CRF) is a major cause of morbidity and mortality and renal replacement dialysis is necessary for the preservation of life, despite the fact that it is characterized by multiple restrictions and complications.
Aim: The purpose of the present systematic review was the investigation of the absolute and relevant renal replacement therapy initiation criteria among patients with end-stage renal disease (ESRD).
Material and Method: There was an extensive research at Pubmed, IATROTEK and Cinahl during the period 2000-2015. The key words that were used for data search included “CRF”, “renal replacement therapy”, “initiation criteria”, “glomerular filtration rate”, and “guidelines”. In the present review, 20 studies were included.
Results: Renal replacement therapy initiation constitutes a challenge for both nephrologists and patients since there is no consensus regarding the initiation criteria. GFR should not be the only marker for the initiation of renal replacement therapy since it is influenced by multiple factors. Renal replacement therapy should start at the presence of uremic signs and symptoms or complications, and co morbidity and individualized characteristics of patients should be taken into account. The doctors’-nephrologists’ characteristics seemed to influence the time of initiation of renal replacement therapy.
Conclusions: CRF patients should be monitored by an interdisciplinary team and for the decision for the renal replacement therapy initiation, a relationship of cooperation between the doctor and the patient should be encouraged.
Article Details
- How to Cite
-
Florou, A., Margari, N., & Theofanidis, D. (2016). Indications of initiation renal replacement therapy among patients with chronic renal disease. Health & Research Journal, 2(3), 163–177. https://doi.org/10.12681/healthresj.19702
- Section
- Reviews
Copyright notice:
Authors retain copyright of their work and grant the Health and Research Journal the right of first publication.
License:
Articles are published under the Creative Commons Attribution 4.0 International License (CC BY 4.0). This license permits use, sharing, adaptation, distribution, and reproduction in any medium or format, including for commercial purposes, provided that appropriate credit is given to the author(s) and the original publication in this journal, a link to the license is provided, and any changes are indicated.
Attribution requirement:
Any reuse must include the article citation and DOI (where available), and indicate if changes were made.